Search This Blog

Wednesday, August 14, 2019

Stealth BioTherapeutics EPS beats by $0.04

Stealth BioTherapeutics (NASDAQ:MITO): Q2 GAAP EPS of -$0.04 beats by $0.04.
Cash and cash equivalents of $53.2M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)